Article Versions Notes

Roviello G, Catalano M, Santi R, Palmieri VE, Vannini G, Galli IC, Buttitta E, Villari D, Rossi V, Nesi G. Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives. Cancers. 2021; 13(17):4411. https://doi.org/10.3390/cancers13174411

Roviello, Giandomenico, Martina Catalano, Raffaella Santi, Valeria Emma Palmieri, Gianmarco Vannini, Ilaria Camilla Galli, Eleonora Buttitta, Donata Villari, Virginia Rossi, and Gabriella Nesi. 2021. "Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives" Cancers 13, no. 17: 4411. https://doi.org/10.3390/cancers13174411

Roviello, G., Catalano, M., Santi, R., Palmieri, V. E., Vannini, G., Galli, I. C., Buttitta, E., Villari, D., Rossi, V., & Nesi, G. (2021). Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives. Cancers, 13(17), 4411. https://doi.org/10.3390/cancers13174411